rethinkTHC Search
Menu
Study breakdown

Parents Secretly Gave CBD to Their Sick 4-Year-Old, Highlighting Legalization-Era Risks

Case ReportPreliminary evidence
The takeaway

A case report described parents who secretly administered a CBD extract to their 4-year-old child with brain inflammation, not informing physicians because they believed the product was legal and therefore safe.

Pediatricians; neurologists treating children; parents considering CBD for their children; medical ethicists.

Parents equated "legal" with "safe" and did not inform treating physicians

What the researchers found

A 4-year-old with anti-NMDA receptor encephalitis tested positive for cannabis and other substances during investigation of treatment-resistant behavioral disturbances. The parents disclosed administering a CBD extract as a "home remedy" for behavior management. They did not inform physicians because they considered the product legal.

Why it matters

As CBD products become widely available and marketed as safe, some parents may administer them to children without medical guidance. This case illustrates the risks: unknown interactions with medical treatments, unpredictable effects in a sick child, and interference with clinical decision-making.

The numbers in context

4-year-old child. Diagnosis: anti-NMDA receptor encephalitis. Found positive for cannabis and other substances. Parents disclosed CBD extract administration without medical knowledge.

How the study worked

Case report from an Italian pediatric hospital. Drug testing was performed to investigate unexplained behavioral changes in a child undergoing treatment for autoimmune encephalitis. Toxicologic analysis extended to parents, leading to disclosure.

What this study cannot tell us

Single case report cannot establish frequency of this behavior. The specific CBD product was not characterized. The contribution of CBD to the child's behavioral changes could not be definitively determined.

How to read the evidence

Preliminary: single case report, but raises important safety and ethical issues.

When this study was published

Published in 2022.

The bigger picture

The assumption that "legal equals safe" is a growing public health concern. This case shows how cannabis legalization and CBD marketing can lead to well-intentioned but potentially harmful parental self-prescribing, particularly for children with complex neurological conditions.

Questions still open

  • How common is parental CBD administration to children without medical guidance? Should clinicians routinely screen for cannabinoid use in pediatric patients? Would clearer product labeling reduce unauthorized administration to children?

Common questions

Is it safe to give CBD to children?
This case report highlights the risks of giving CBD to children without medical supervision, especially those with complex medical conditions. CBD can interact with medications and its effects in sick children are unpredictable. Any CBD use in children should involve the treating physician.
Why didn't the parents tell the doctors?
The parents believed the CBD product was legal and therefore safe, seeing no need to disclose it. This reflects a common misconception that legal availability equals medical safety, particularly dangerous when treating seriously ill children.

Read the original research

Is Cannabis Legalization Eliciting Abusive Behaviors in Parents? A Case Report.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 27(5), 470-475

Citation

Russo, Marianna; Favretto, Donata; Sartori, Stefano; Facchin, Paola; Rosa-Rizzotto, Melissa. (2022). Is Cannabis Legalization Eliciting Abusive Behaviors in Parents? A Case Report.. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 27(5), 470-475. https://doi.org/10.5863/1551-6776-27.5.470

Explore the wider topic